Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Spanningsveld tussen registreren en verbeteren van zorgkwaliteit
dec 2018 | Bewegingsstoornissen